Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-028686
Date:2022-05-11
Issuer: TRAVERE THERAPEUTICS, INC. (TVTX)
Original Submission Date:

Reporting Person:

BRUHN SUZANNE LOUISE
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300 SAN DIEGO, CA 92130

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-05-11 A 3,000 a $0.00 11,250 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 21.38 2022-05-11 deemed execution date A 9,000 (a) 2023-05-11 2032-05-10 common stock 9,000 $21.38 9,000 direct
Footnotes
IDfootnote
f1 automatic equity grant under the issuer's 2018 equity incentive plan, as amended, pursuant to the non-employee director compensation program.
f2 the equity award vests over a one year period.
WhaleWisdom Logo

Elevate your investments